作者: Victor Rodriguez Freixinos , Stephanie Lheureux , Victoria Mandilaras , Blaise Clarke , Neesha Dhani
DOI: 10.1200/JCO.2016.34.15_SUPPL.5509
关键词:
摘要: 5509Background: Rare gynaecologic cancers (R-GYN) represent over 50% of all malignancies. Conducting clinical trials in R-GYN is challenging due to the limited number patients (pts)...